Teva Pharmaceutical Industries Limited
General ticker "TEVJF" information:
- Sector: Health Care
- Industry: Pharmaceuticals
- Capitalization: $19.1B (TTM average)
Teva Pharmaceutical Industries Limited follows the US Stock Market performance with the rate: 23.8%.
Estimated limits based on current volatility of 0.1%: low 16.11$, high 16.13$
Factors to consider:
- US accounted for 38.2% of revenue in the fiscal year ended 2024-12-31
- Current price 63.2% above estimated high
- Earnings for 15 months up through Q1 (+1 year) are below our estimates
Stock Forecast*
* forecast is subjective and experimental, should not be used for any investment decisions
Long term estimates were made for the period from 2023-12-31 to 2025-12-30
- 2023-12-31 to 2024-12-30 estimated range: [5.63$, 10.77$]
- 2024-12-30 to 2025-12-30 estimated range: [4.89$, 9.87$]
Financial Metrics affecting the TEVJF estimates:
- Negative: Non-GAAP EPS, $ of -0.54 <= 0.04
- Positive: Operating cash flow per share per price, % of 13.48 > 12.73
- Negative: negative Net income
- Negative: Shareholder equity ratio, % of 17.26 <= 22.52
- Positive: -0.07 < Operating profit margin, % of 2.72
- Positive: Interest expense per share, $ of 0 <= 0
- Positive: Industry inventory ratio change (median), % of -2.82 <= -0.28
Short-term TEVJF quotes
Long-term TEVJF plot with estimates
Financial data
| YTD | 2022-12-31 | 2023-12-31 | 2024-12-31 |
|---|---|---|---|
| Operating Revenue | $15,032.00MM | $15,895.00MM | $16,558.00MM |
| Operating Expenses | $17,229.00MM | $15,462.00MM | $16,861.00MM |
| Operating Income | $-2,197.00MM | $433.00MM | $-303.00MM |
| Non-Operating Income | $-966.00MM | $-1,057.00MM | $-981.00MM |
| R&D Expense | $838.00MM | $953.00MM | $998.00MM |
| Income(Loss) | $-3,163.00MM | $-624.00MM | $-1,284.00MM |
| Taxes | $-643.00MM | $-7.00MM | $676.00MM |
| Other Income(Loss) | $21.00MM | $2.00MM | $1.00MM |
| Profit(Loss)* | $-2,446.00MM | $-559.00MM | $-1,639.00MM |
| Stockholders Equity | $7,804.00MM | $7,506.00MM | $5,373.00MM |
| Inventory | $3,833.00MM | $4,021.00MM | $3,007.00MM |
| Assets | $44,011.00MM | $43,479.00MM | $39,326.00MM |
| Operating Cash Flow | $1,590.00MM | $1,368.00MM | $1,247.00MM |
| Capital expenditure | $548.00MM | $526.00MM | $498.00MM |
| Investing Cash Flow | $656.00MM | $968.00MM | $792.00MM |
| Financing Cash Flow | $-1,487.00MM | $-1,913.00MM | $-1,791.00MM |
| Earnings Per Share** | $-2.20 | $-0.50 | $-1.45 |
* Profit(Loss) attributable to entity.
** EPS are Split Adjusted, recent splits may be reflected with a delay.